Marco Colleoni
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Cancer Research 249
- Breast Cancer Treatment Studies 228
- Oncology 277
- Cancer Treatment and Pharmacology 119
- HER2/EGFR in Cancer Research 117
- Lung Cancer Research Studies 22
- Cancer-related Molecular Pathways 20
- Co-authors
- Aron GoldhirschGiuseppe VialeAlan S. CoatesPaolo VeronesiRichard D. GelberAlberto LuiniNicole RotmenszKaren N. Price
- Journals
- Journal of Clinical Oncology (72 papers)Annals of Oncology (67 papers)The Breast (35 papers)Cancer Research (33 papers)Breast Cancer Research and Treatment (26 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Marco Colleoni
413 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 10.2k
- Oncology 12.6k
- Pulmonary and Respiratory Medicine 6.5k
- Pathology and Forensic Medicine 3.2k
- Genetics 1.3k
Countries citing papers authored by Marco Colleoni
This map shows the geographic impact of Marco Colleoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Colleoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Colleoni more than expected).
Fields of papers citing papers by Marco Colleoni
This network shows the impact of papers produced by Marco Colleoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Colleoni. The network helps show where Marco Colleoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Colleoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study Hit paper breakdown → | 2022 | 204 |
| 8 | 2020 | 5 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 98 | |
| 11 | 2018 | 110 | |
| 12 | Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014) | 2017 | 5 |
| 13 | 2016 | 3 | |
| 14 | 2012 | 102 | |
| 15 | 2011 | 51 | |
| 16 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Hit paper breakdown → | 2009 | 581 |
| 17 | Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. | 2009 | 14 |
| 18 | 2008 | 38 | |
| 19 | 2007 | 93 | |
| 20 | Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma. | 2004 | 27 |
About Marco Colleoni
Marco Colleoni is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 421 papers that have together received 19.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (228 papers), Advanced Breast Cancer Therapies (120 papers), Cancer Treatment and Pharmacology (119 papers), HER2/EGFR in Cancer Research (117 papers), Estrogen and related hormone effects (73 papers), Breast Lesions and Carcinomas (66 papers), Lung Cancer Research Studies (22 papers) and Cancer-related Molecular Pathways (20 papers). The work is most often cited by research in Cancer Research (10.2k citations), Oncology (12.6k citations), Pulmonary and Respiratory Medicine (6.5k citations), Pathology and Forensic Medicine (3.2k citations) and Genetics (1.3k citations). Marco Colleoni has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Aron Goldhirsch, Giuseppe Viale, Alan S. Coates, Paolo Veronesi, Richard D. Gelber, Alberto Luini, Nicole Rotmensz, Karen N. Price, Beat Thürlimann and Mattia Intra. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Breast, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.